Nanoco Group plc

Nanoco Group plc and its affiliated entities are pioneers in the research, development, manufacturing, and licensing of innovative nanomaterials tailored for a wide array of commercial uses. Their product line features CFQD quantum dots, which are fluorescent semiconductor nanoparticles primarily utilized for superior color conversion in OLED and µLED displays, advanced QD-EL applications, and secure tagging solutions. They also provide CFQD fine color films. For the sensor industry, the company offers HEATWAVE quantum dots, while VIVODOTS nanoparticles are designed for medical and veterinary sectors. Nanoco maintains a global operational footprint, spanning the United Kingdom, broader Europe, Asia, and the United States. The company, founded in 2001 and headquartered in Manchester, UK, was formerly known as Evolutec Group plc before rebranding to Nanoco Group plc in April 2009.

Nanoco Group plc trades as NANO.L on LSE. The company is classified in Technology / Semiconductors and reports in GBP.

The current profile places the business in Semiconductors. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £7.62M of revenue and -£2.20M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Nanoco Group plc can be compared against peers such as Altitude Group plc, Checkit plc, CAP-XX Limited, Cordel Group Plc, GSTechnologies Ltd., Itim Group Plc.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £4.83M, beta of -0.09, and return on equity of +11.3%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

NANO.L currently shows total debt of £1.30M and beta of -0.09. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.nanocotechnologies.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.